Edition:
United Kingdom

Sawai Pharmaceutical Co Ltd (4555.T)

4555.T on Tokyo Stock Exchange

5,850JPY
19 Apr 2019
Change (% chg)

¥-20 (-0.34%)
Prev Close
¥5,870
Open
¥5,880
Day's High
¥5,900
Day's Low
¥5,820
Volume
113,900
Avg. Vol
202,992
52-wk High
¥6,660
52-wk Low
¥4,570

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 100.52 March 20 Apr 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 0
(2) OUTPERFORM 3 5 5 5
(3) HOLD 5 5 5 5
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.60 2.50 2.50 2.64

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 1 45,300.00 45,300.00 45,300.00 --
Quarter Ending Dec-19 1 49,500.00 49,500.00 49,500.00 --
Year Ending Mar-19 10 178,200.00 181,500.00 172,500.00 184,188.00
Year Ending Mar-20 10 184,600.00 190,100.00 178,600.00 197,557.00
Earnings (per share)
Quarter Ending Sep-19 1 100.52 100.52 100.52 --
Quarter Ending Dec-19 1 148.50 148.50 148.50 --
Year Ending Mar-19 11 447.62 564.30 418.10 422.57
Year Ending Mar-20 11 463.41 518.61 392.93 456.06
LT Growth Rate (%) 2 3.01 9.82 -3.80 1.14

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 46,704.00 49,205.00 2,501.00 5.36
Quarter Ending Sep-18 42,652.00 43,494.00 842.00 1.97
Quarter Ending Jun-18 42,650.00 45,298.00 2,648.00 6.21
Quarter Ending Mar-18 50,411.00 51,529.00 1,118.00 2.22
Quarter Ending Dec-17 47,800.00 45,781.00 2,019.00 4.22

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 45,300.00 45,300.00 45,300.00 45,300.00 --
Quarter Ending Dec-19 49,500.00 49,500.00 49,500.00 49,500.00 --
Year Ending Mar-19 178,200.00 178,200.00 177,180.00 177,110.00 184,188.00
Year Ending Mar-20 184,600.00 184,600.00 184,270.00 184,736.00 197,557.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 0 0 0
Quarter Ending Dec-19 0 0 0 0
Year Ending Mar-19 0 0 2 0
Year Ending Mar-20 0 0 2 0
Earnings